207 related articles for article (PubMed ID: 12805651)
21. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
22. Development of an updated PBPK model for trichloroethylene and metabolites in mice, and its application to discern the role of oxidative metabolism in TCE-induced hepatomegaly.
Evans MV; Chiu WA; Okino MS; Caldwell JC
Toxicol Appl Pharmacol; 2009 May; 236(3):329-40. PubMed ID: 19249323
[TBL] [Abstract][Full Text] [Related]
23. Risk assessment of inhaled chloroform based on its mode of action.
Wolf DC; Butterworth BE
Toxicol Pathol; 1997; 25(1):49-52. PubMed ID: 9061851
[TBL] [Abstract][Full Text] [Related]
24. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
[TBL] [Abstract][Full Text] [Related]
25. In vivo metabolism of chloroform in B6C3F1 mice determined by the method of gas uptake: the effects of body temperature on tissue partition coefficients and metabolism.
Gearhart JM; Seckel C; Vinegar A
Toxicol Appl Pharmacol; 1993 Apr; 119(2):258-66. PubMed ID: 8480334
[TBL] [Abstract][Full Text] [Related]
26. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments.
Butterworth BE; Conolly RB; Morgan KT
Cancer Lett; 1995 Jun; 93(1):129-46. PubMed ID: 7600540
[TBL] [Abstract][Full Text] [Related]
27. In vivo CHCl3 bioactivation, toxicokinetics, toxicity, and induced compensatory cell proliferation in B6C3F1 male mice.
Gemma S; Faccioli S; Chieco P; Sbraccia M; Testai E; Vittozzi L
Toxicol Appl Pharmacol; 1996 Dec; 141(2):394-402. PubMed ID: 8975764
[TBL] [Abstract][Full Text] [Related]
28. Biologically based dose response model for hepatic toxicity: a mechanistically based replacement for traditional estimates of noncancer risk.
Conolly RB; Butterworth BE
Toxicol Lett; 1995 Dec; 82-83():901-6. PubMed ID: 8597160
[TBL] [Abstract][Full Text] [Related]
29. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
Kirman CR; Sweeney LM; Corley R; Gargas ML
Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
[TBL] [Abstract][Full Text] [Related]
30. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
Preston RJ
Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
[TBL] [Abstract][Full Text] [Related]
31. Manganese tissue dosimetry in rats and monkeys: accounting for dietary and inhaled Mn with physiologically based pharmacokinetic modeling.
Nong A; Taylor MD; Clewell HJ; Dorman DC; Andersen ME
Toxicol Sci; 2009 Mar; 108(1):22-34. PubMed ID: 19098275
[TBL] [Abstract][Full Text] [Related]
32. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
[TBL] [Abstract][Full Text] [Related]
33. NTP Toxicology and Carcinogenesis Studies of 1,3-Butadiene (CAS No. 106-99-0) in B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 May; 434():1-389. PubMed ID: 12616297
[TBL] [Abstract][Full Text] [Related]
34. Physiologically-based pharmacokinetic and toxicokinetic models in cancer risk assessment.
Krishnan K; Johanson G
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005; 23(1):31-53. PubMed ID: 16291521
[TBL] [Abstract][Full Text] [Related]
35. NTP Toxicology and Carcinogenesis Studies 2-Butoxyethanol (CAS NO. 111-76-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Mar; 484():1-290. PubMed ID: 12571679
[TBL] [Abstract][Full Text] [Related]
36. Risk assessment of nongenotoxic carcinogens based upon cell proliferation/death rates in rodents.
Gaylor DW; Zheng Q
Risk Anal; 1996 Apr; 16(2):221-5. PubMed ID: 8638041
[TBL] [Abstract][Full Text] [Related]
37. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
38. Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling.
Reitz RH; Mendrala AL; Corley RA; Quast JF; Gargas ML; Andersen ME; Staats DA; Conolly RB
Toxicol Appl Pharmacol; 1990 Sep; 105(3):443-59. PubMed ID: 2237918
[TBL] [Abstract][Full Text] [Related]
39. The role of regenerative cell proliferation in chloroform-induced cancer.
Butterworth BE; Templin MV; Borghoff SJ; Conolly RB; Kedderis GL; Wolf DC
Toxicol Lett; 1995 Dec; 82-83():23-6. PubMed ID: 8597058
[TBL] [Abstract][Full Text] [Related]
40. A distributed parameter physiologically-based pharmacokinetic model for dermal and inhalation exposure to volatile organic compounds.
Roy A; Weisel CP; Lioy PJ; Georgopoulos PG
Risk Anal; 1996 Apr; 16(2):147-60. PubMed ID: 8638037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
